The French Competition Authority expresses interest in the discounts granted by generics firms to pharmacies (Pharmaceutical sector inquiry)

During the launch of its pharmaceutical sector inquiry in November 2017, the French Competition Authority (FCA) expressed interest in the discounts granted by generics firms to pharmacies. [1] The FCA quoted the decision issued following the previous sector inquiry carried out in 2013, which "had revealed that pharmacies benefit from substantial discounts on those [generic] drugs, which are nevertheless very rarely redistributed to the final consumer and to the public health insurance scheme." According to the annual report on social security published by the Court of Auditors in 2017, these discounts amounted to 1.1 billion euros in 2015. [2] The public consultations carried out in the context of the FCA's 2013 decision [3] had, however, resulted in greater transparency of the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Alexandre Carbonnel, The French Competition Authority expresses interest in the discounts granted by generics firms to pharmacies (Pharmaceutical sector inquiry), 20 November 2017, e-Competitions Bulletin November 2017, Art. N° 87693

Visites 73

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues